Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00851084
What this trial is testing

Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Sanofi 268
Early research (Phase 1)Study completedNCT00532909
What this trial is testing

Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

Who this might be right for
Anal, Colon, and Rectal CancersColorectal NeoplasmsColon/Rectal Cancer
Branimir Sikic 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515963
What this trial is testing

FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

Who this might be right for
Colo-rectal Cancer
Zhongnan Hospital 24
Large-scale testing (Phase 3)UnknownNCT00797485
What this trial is testing

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Southern Italy Cooperative Oncology Group 672
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07059949
What this trial is testing

Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer

Who this might be right for
Unresectable Metastatic Rectal CancerCAPOXCombination of Radioimmunotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Large-scale testing (Phase 3)Study completedNCT00268398
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases

Who this might be right for
Colorectal CancerMetastatic CancerChemotherapy
GERCOR - Multidisciplinary Oncology Cooperative Group 284
Large-scale testing (Phase 3)Ended earlyNCT00544700
What this trial is testing

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 265
Testing effectiveness (Phase 2)Study completedNCT00004142
What this trial is testing

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00039273
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT00257322
What this trial is testing

Cellular Immune Augmentation in Colon and Rectal Cancer

Who this might be right for
Colon CancerRectal Cancer
University of California, Irvine 20
Testing effectiveness (Phase 2)UnknownNCT05359406
What this trial is testing

A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis

Who this might be right for
Advanced Rectal CancerDistal Metastasis
LI XIN-XIANG 51
Large-scale testing (Phase 3)Study completedNCT00002716
What this trial is testing

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 135
Large-scale testing (Phase 3)UnknownNCT00002793
What this trial is testing

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Johann Wolfgang Goethe University Hospital 336
Testing effectiveness (Phase 2)Ended earlyNCT00070265
What this trial is testing

Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+2 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT01294826
What this trial is testing

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+3 more
Swedish Medical Center 20
Not applicableEnded earlyNCT03634202
What this trial is testing

Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer

Who this might be right for
Rectal CancerMetastasisRadiotherapy
Institut Cancerologie de l'Ouest 9
Testing effectiveness (Phase 2)Study completedNCT00004102
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
NYU Langone Health
Early research (Phase 1)Study completedNCT04362839
What this trial is testing

Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer

Who this might be right for
Advanced Colon AdenocarcinomaMetastatic Colon AdenocarcinomaMetastatic Colorectal Adenocarcinoma+22 more
City of Hope Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT03436563
What this trial is testing

M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability

Who this might be right for
Colon AdenocarcinomaHigh-Frequency Microsatellite InstabilityMetastatic Malignant Solid Neoplasm+8 more
M.D. Anderson Cancer Center 4
Next Page